PCI method for generating immune respose to antigenic molecule using checkpoint inhibitor and TLR3 ligand
AssigneePCI Biotech AS
InventorAnders Høgset
Life of this patent
Estimating the term…
Abstract
The invention concerns a method of generating an immune response in a subject, comprising administering to the subject an antigenic molecule, a photosensitizing agent, a checkpoint inhibitor, and irradiating said subject with light of a wavelength effective to activate the photosensitizing agent to generate an immune response. Preferably the method is a method of vaccination. The invention also provides related methods, compositions, cells, uses, products and kits.
Claims11
A method of generating an immune response in a subject, comprising administering to a subject an antigenic molecule, a photosensitizing agent, a checkpoint inhibitor and a TLR3 ligand, and irradiating said subject with light of a wavelength effective to activate said photosensitizing agent, wherein an immune response is thereby generated, wherein
- the antigenic molecule is a peptide,
- the checkpoint inhibitor is an anti-CTLA4 antibody, an anti-PD-1 antibody, or both an anti-CTLA4 antibody and an anti-PD-1 antibody, and
- the TLR3 ligand is a double stranded RNA molecule.
Dependencies are inferred from the claim text.